MetLife Investment Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23,363	Closed	-$116K	–	2858
2024 Q3	$116K	Buy	23,363 +13,164	+129%	+$65.6K	﹤0.01%	2569
2024 Q2	$59.7K	Buy	+10,199	New	+$59.7K	﹤0.01%	2731